Leaders in markets for ablation and other energy-based technologies

Medtronic is the predominant player in the energy-based therapies market. With global sales of nearly $4.9 billion attributable to energy-based products, it controls over half of the cardiac rhythm market and almost a quarter of all energy-based product sales. Boston Scientific, also focusing on cardiac arrhythmias, comes next in the revenues table with a $2. 9 billion share. St. Jude Medical, the joint number three player enjoys sales of nearly $2 billion for energy therapies such as implantable defribrillators and pacemakers using electrical energy to restore normal heart rhythm . Varian Medical shares the number three spot with almost $2 million in sales. Varian is the world’s leading manufacturer of integrated cancer therapy systems and markets a full line of linear accelerators for radiation therapy.

With sales of over $800 million for energy-based products, Biosense Webster, a Johnson & Johnson company, comes next in market share. Then comes Covidien (formerly Tyco Healthcare) with its member company Valleylab specialising in devices for electrosurgery and vessel sealing. Smith & Nephew generates sales of $600 million from energy-based therapies including devices for radiofrequency and hydro-ablation. The remaining three companies in the "top ten" each generate annual revenues in the $200-300 million range from energy-based devices; they are Arthrocare, Getinge and Olympus.

 

Market Leaders in Energy-Based Therapies

Company

Product Area

Main indication

AngioDynamics

RF

Lung cancer

Arthrocare

RF

Nucleoplasty

Atricure

RF

Atrial arrhythmias

ATS

Cryogenic

Cardiac arrhythmias

Biosense Webster (J&J)

RF

Atrial arrhythmias

Boston Scientific

RF

Atrial arrhythmias

Candela

Light

Hair removal

CardioGenesis

Light

Angina pectoris

Covidien

RF, Microwave, Ultrasound

Soft tissue ablation

EDAP TMS

Ultrasound

Prostate cancer

Endocare

Cryogenic

Prostate cancer

HealthTronics

Light

BPH

Maquette (Getinge)

RF

Hepatic cancer

Medtronic

Electrical

Tachyarrhythmia

Olympus

RF

Gynaecology, ENT, soft tissue ablation

Smith & Nephew

RF, Hydro

Soft tissue ablation, Capsular shrinkage

St Jude

Electrical

Cardiac arrhythmias

TheraGenics

Radiation

Prostate cancer

Varian

Radiation

Cancer

VNUS

RF

Saphenous vein closure

Source: MedMarket Diligence, LLC


The above is an excerpt from report #A125, "Ablation Technologies Worldwide Market, 2008," published September 2008.

 

 

Leave a Reply